Skip to main content

Table 1 Patient characteristics

From: Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life

Total number of patients

92

Age, mean (range)

75 (57–92)

Males n (%)

67 (73)

Duration of IPF in years, mean (SD)

3.6 (2.3)

Education in years, mean (SD)

10 (3)

Living alone, n (%)

31 (34)

Working, n (%)

4 (4)

Smoking status, n (%)a

 Smoker

6 (7)

 Ex-smoker

50 (54)

 Never-smoker

36 (39)

FVC (litres), mean (SD)b

2.9 (0.8)

FVC (% of predicted), mean (SD)b

78 (16)

Diffusion capacity, mean(SD)c

54 (13)

Co-morbiditiese, n (%)

 Hypertension

41 (45)

 Coronary heart disease

35 (38)

 Diabetes

24 (26)

 Heart failure

23 (25)

 COPD

20 (22)

 Cancer

16 (17)

 Asthma

8 (9)

 No co-morbidities

13 (14)

Number of co-morbidities, median (range)

2 (0–7)

Place of death, n (%)b

 Hospitald

62 (67)

 Home

19 (22)

 Nursing home

4 (5)

 Hospice

3 (3)

  1. asmoking status, forced volume vital capacity (FVC) and diffusion capacity are recorded at the time of diagnosis and other factors at the time of the first questionnaire
  2. bData missing from 4 patients; c data missing from 12 patients; d10 in intensive care unit; e patient-reported co-morbidities